Literature DB >> 8380478

The neurologic complications of human immunodeficiency virus infection.

J R Berger1, R M Levy.   

Abstract

The physician caring for HIV-1-infected patients must have a good working knowledge of the broad spectrum of neurologic diseases that occur in association with this infection. As with any other neurologic disorder, the site of the neuraxis that is affected must be properly identified. In HIV-1-infected persons, more than one site may be involved simultaneously, such as the coexistence of myelopathy and peripheral neuropathy, often resulting in a confusing array of neurologic signs and symptoms. The frequent occurrence of two or more diseases affecting the neuraxis, such as progressive multifocal leukoencephalopathy and toxoplasmosis, further complicates the picture. With the AIDS patient, the physician cannot rely on the clinical adage that all attempts should be made to ascribe the patient's problems to one disease. Often, it is not the case. As with other illnesses, the approach to the HIV-1-infected person with neurologic disease needs to be thorough and fluid. After rendering a diagnosis and embarking on therapy, the physician needs to be open minded about the possibility of an incorrect or additional diagnosis not previously considered. Lastly, despite all the knowledge that has been accumulated in the first decade of the AIDS epidemic, new illnesses occurring with HIV-1 infection are recognized with regularity. The physician must always bear in mind that the illness with which he or she is confronted may be one that has not been previously described.

Entities:  

Mesh:

Year:  1993        PMID: 8380478     DOI: 10.1016/s0025-7125(16)30269-3

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  9 in total

1.  Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 2.  Neuroleptic malignant syndrome in the acquired immunodeficiency syndrome.

Authors:  J L Hernández; L Palacios-Araus; S Echevarría; A Herrán; J F Campo; J A Riancho
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

3.  Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication.

Authors:  T Glück; E Degenhardt; J Schölmerich; B Lang; J Grossmann; R H Straub
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

4.  CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.

Authors:  Sonia K Bhangoo; Dongjun Ren; Richard J Miller; David M Chan; Matthew S Ripsch; Clarissa Weiss; Christian McGinnis; Fletcher A White
Journal:  Brain Behav Immun       Date:  2007-02-09       Impact factor: 7.217

5.  Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness.

Authors:  Joseph R Berger; Dominic B Fee; Peter Nelson; Gerald Nuovo
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

Review 6.  Opportunistic infections of the CNS in patients with AIDS: diagnosis and management.

Authors:  Julio Collazos
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania.

Authors:  H T Agostini; G R Brubaker; J Shao; A Levin; C F Ryschkewitsch; W A Blattner; G L Stoner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Differential expression of mRNAs for JC virus large and small tumor antigens in brain tissues from progressive multifocal leukoencephalopathy patients with and without AIDS.

Authors:  M Ishaq; G L Stoner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.

Authors:  Andrew D Piekarz; Michael R Due; May Khanna; Bo Wang; Matthew S Ripsch; Ruizhong Wang; Samy O Meroueh; Michael R Vasko; Fletcher A White; Rajesh Khanna
Journal:  Mol Pain       Date:  2012-07-24       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.